All News
STAT+: Pfizer’s abrupt withdrawal of sickle cell drug Oxbryta called ‘tone deaf’ at ASH conference
Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf”
Read More'You Don't Just Shoot an Arrow at It': What We Heard This Week
(MedPage Today) -- "You don't just shoot an arrow at it ... you throw a grenade, fire a torpedo, and drown it all at once.
Read MoreNovel BTK Inhibitor Succeeds in Heavily Pretreated Immune Thrombocytopenia
(MedPage Today) -- SAN DIEGO -- Treatment with an investigational oral inhibitor of Bruton's tyrosine kinase (BTK) was safe and boosted platelet counts in heavily pretreated patients with immune th
Read MoreLoncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
(MedPage Today) -- SAN DIEGO -- The combination of loncastuximab tesirine (Zynlonta) and rituximab achieved promising response rates in patients with relapsed or refractory follicular lymphoma (R/R
Read MoreTrump suggests he shares some of RFK Jr.’s concerns about childhood vaccines
President-elect Trump suggested in an interview that he shares some of the concerns voiced by RFK Jr.
Read MoreDietary Intervention Shows Promise in Blood Cancers
(MedPage Today) -- SAN DIEGO -- Increased dietary fiber had a significant association with improved outcomes in blood cancers, according to studies reported here.
Read MoreLabour needs the will to solve social care crisis | Letters
A free adult social care system modelled on one already in operation in a London borough is achievable, according to Sally Powell and Stephen Burke.
Read MoreHospitalization Should Not Mean Financial Ruin for Medicare Beneficiaries
(MedPage Today) -- Medicare was created to ensure older adults in the U.S. have healthcare coverage while protecting them from financial ruin.
Read MoreStudy paints clearer picture of disadvantaged leukemia patients’ struggle to get bone marrow transplants
Study reveals how socioeconomic factors create barriers to bone marrow transplants for AML patients in disadvantaged communities
Read MoreAre GLP-1 Drug Holidays a Risk Worth Taking?
(MedPage Today) -- In part three of this three-part Instagram Live discussion, MedPage Today editor-in-chief Jeremy Faust, MD, Karl Nadolsky, DO, and Fatima Cody Stanford, MD, MPH, MPA, MBA, explore
Read More